Antagonism of Adherent Invasive E. coli LF82 With Human α-defensin 5 in the Follicle-associated Epithelium of Patients With Ileal Crohn’s DiseaseShow others and affiliations
2021 (English)In: Inflammatory Bowel Diseases, ISSN 1078-0998, E-ISSN 1536-4844, Vol. 27, no 7, p. 1116-1127Article in journal (Refereed) Published
Abstract [en]
Background: The first visible signs of Crohns disease (CD) are microscopic erosions over the follicle-associated epithelium (FAE). The aim of the study was to investigate the effects of human alpha-defensin 5 (HD5) on adherent-invasive Escherichia coli LF82 translocation and HD5 secretion after LF82 exposure in an in vitro model of human FAE and in human FAE ex vivo. Methods: An in vitro FAE-model was set up by the coculture of Raji B cells and Caco-2-cl1 cells. Ileal FAE from patients with CD and controls were mounted in Ussing chambers. The effect of HD5 on LF82 translocation was studied by LF82 exposure to the cells or tissues with or without incubation with HD5. The HD5 secretion was measured in human FAE exposed to LF82 or Salmonella typhimurium. The HD5 levels were evaluated by immunofluorescence, immunoblotting, and ELISA. Results: There was an increased LF82 translocation across the FAE-model compared with Caco-2-cl1 (P < 0.05). Incubation of cell/tissues with HD5 before LF82 exposure reduced bacterial passage in both models. Human FAE showed increased LF82 translocation in CD compared with controls and attenuated passage after incubation with sublethal HD5 in both CD and controls (P < 0.05). LF82 exposure resulted in a lower HD5 secretion in CD FAE compared with controls (P < 0.05), whereas Salmonella exposure caused equal secretion on CD and controls. There were significantly lower HD5 levels in CD tissues compared with controls. Conclusions: Sublethal HD5 reduces the ability of LF82 to translocate through FAE. The HD5 is secreted less in CD in response to LF82, despite a normal response to Salmonella. This further implicates the integrated role of antimicrobial factors and barrier function in CD pathogenesis.
Place, publisher, year, edition, pages
OXFORD UNIV PRESS INC , 2021. Vol. 27, no 7, p. 1116-1127
Keywords [en]
inflammatory bowel disease; antimicrobial peptides; barrier function
National Category
Clinical Medicine Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:liu:diva-177745DOI: 10.1093/ibd/izaa315ISI: 000670937700021OAI: oai:DiVA.org:liu-177745DiVA, id: diva2:1576965
Note
Funding: International Organization For the Study of Inflammatory Bowel Disease (IOIBD); Lions Clubs International Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2014-02537, 2017-02475]; ALF Grants Region Ostergotland
2021-07-012021-07-012024-03-01Bibliographically approved